Matthew Richard Moore, SVP and Chief Business Officer at Arcutis Biotherapeutics, holds 145.50K shares in Arcutis Biotherapeutics (Ticker: ARQT), holds ― shares in Ventyx Biosciences (Ticker: VTYX).

See the Hottest Stocks Based on Insider Trading >

Matthew Richard Moore
Arcutis Biotherapeutics (ARQT)
SVP and Chief Business Officer

Not Ranked

Matthew Richard Moore has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

ARQT

0.00%

VTYX

A breakdown of Matthew Richard Moore's holdings

See the Top Stocks by Insiders

Insider Roles

Arcutis Biotherapeutics
(ARQT)

SVP and Chief Business Officer

Ventyx Biosciences
(VTYX)

Chief Operating Officer

Roles that Matthew Richard Moore holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Arcutis Biotherapeutics
(ARQT)

Rating:Informative Sell

Date:May 03, 2024 - Today

Return:-14.50%

The most profitable trade made by Matthew Richard Moore

See the Latest Stocks Traded by Insiders

Matthew Richard Moore's Trading History

ARQT

Arcutis Biotherapeutics

May 03, 2024

SVP and Chief Business Officer

Uninformative Buy

―

$1.33M

VTYX

Ventyx Biosciences

―

Chief Operating Officer

―

List of latest transactions for each holding click on a transaction to see Matthew Richard Moore's performance on stock

See All Insider Trading from Today

Matthew Richard Moore insider profile FAQ

What is the percentage of profitable transactions made by Matthew Richard Moore?

The percentage of profitable transactions made by Matthew Richard Moore is ―.

What is the average return per transaction made by Matthew Richard Moore?

The average return per transaction made by Matthew Richard Moore is ―.

What stocks does Matthew Richard Moore hold?

Matthew Richard Moore holds: ARQT, VTYX stocks.

What was Matthew Richard Moore’s latest transaction?

Matthew Richard Moore latest transaction was an Uninformative Buy of ―.

What was Matthew Richard Moore's most profitable transaction?

Matthew Richard Moore’s most profitable transaction was an Informative Sell of ARQT stock on May 3, 2024. The return on the trade was -14.50%.

What is Matthew Richard Moore's role in Arcutis Biotherapeutics?

Matthew Richard Moore's role in Arcutis Biotherapeutics is SVP and Chief Business Officer.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Matthew Richard Moore Insider Profile

Matthew Richard Moore Arcutis Biotherapeutics (ARQT)SVP and Chief Business Officer